Stephens Inc. AR Has $2.14 Million Position in Cigna Group $CI

Stephens Inc. AR raised its position in shares of Cigna Group (NYSE:CI) by 4.9% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 6,484 shares of the health services provider’s stock after purchasing an additional 301 shares during the quarter. Stephens Inc. AR’s holdings in Cigna Group were worth $2,143,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the stock. Valeo Financial Advisors LLC increased its stake in shares of Cigna Group by 86,071.1% in the second quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock worth $1,148,859,000 after acquiring an additional 3,471,249 shares during the last quarter. Nuveen LLC acquired a new position in shares of Cigna Group in the first quarter worth $727,905,000. Price T Rowe Associates Inc. MD increased its stake in shares of Cigna Group by 10.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock worth $3,966,690,000 after acquiring an additional 1,094,327 shares during the last quarter. GQG Partners LLC increased its stake in shares of Cigna Group by 21.5% in the first quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock worth $1,607,716,000 after acquiring an additional 865,092 shares during the last quarter. Finally, Goldman Sachs Group Inc. increased its stake in shares of Cigna Group by 38.3% in the first quarter. Goldman Sachs Group Inc. now owns 1,649,837 shares of the health services provider’s stock worth $542,796,000 after acquiring an additional 457,052 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insider Buying and Selling at Cigna Group

In other news, insider Brian C. Evanko sold 5,368 shares of the business’s stock in a transaction dated Friday, October 3rd. The shares were sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the transaction, the insider owned 51,182 shares in the company, valued at approximately $15,354,600. The trade was a 9.49% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Nicole S. Jones sold 28,526 shares of the business’s stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the transaction, the insider owned 25,648 shares in the company, valued at approximately $7,694,400. The trade was a 52.66% decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.70% of the company’s stock.

Cigna Group Stock Performance

Shares of CI opened at $308.30 on Thursday. The company has a market capitalization of $82.30 billion, a PE ratio of 16.83, a price-to-earnings-growth ratio of 0.90 and a beta of 0.45. Cigna Group has a one year low of $256.89 and a one year high of $350.00. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. The company’s fifty day moving average price is $298.83 and its 200 day moving average price is $307.81.

Cigna Group (NYSE:CI) last announced its earnings results on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, topping the consensus estimate of $7.15 by $0.05. The firm had revenue of $67.13 billion for the quarter, compared to the consensus estimate of $62.61 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The business’s quarterly revenue was up 11.0% on a year-over-year basis. During the same quarter last year, the firm posted $6.72 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, analysts expect that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, December 18th. Investors of record on Thursday, December 4th will be issued a $1.51 dividend. This represents a $6.04 annualized dividend and a yield of 2.0%. The ex-dividend date is Thursday, December 4th. Cigna Group’s dividend payout ratio (DPR) is 32.97%.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the stock. Guggenheim reaffirmed a “buy” rating and issued a $350.00 price target (down from $388.00) on shares of Cigna Group in a research note on Monday, August 4th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $365.00 price objective on shares of Cigna Group in a research note on Tuesday, August 26th. Weiss Ratings reissued a “hold (c+)” rating on shares of Cigna Group in a research report on Wednesday, October 8th. Royal Bank Of Canada restated an “outperform” rating and set a $371.00 target price on shares of Cigna Group in a report on Thursday, June 26th. Finally, Wells Fargo & Company upped their price target on Cigna Group from $340.00 to $354.00 and gave the stock an “equal weight” rating in a research note on Tuesday, October 7th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, Cigna Group presently has a consensus rating of “Moderate Buy” and an average target price of $369.89.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.